The plea claimed that the representations of SMTA and different stakeholders weren’t thought-about on the time of taking the choice.
The court docket listed the matter for listening to with a petition moved final yr by SMTA difficult a notification which declared blood monitoring gadgets, digital thermometers, nebulizers and glucometers as ‘medicine’ underneath the Medication and Cosmetics Act.
The bench stated each the issues shall be heard on January 29, 2021.
SMTA, represented by advocate Adit S Pujari, has contended that the notification is unreasonable, arbitrary, and would trigger “undue hardship to stakeholders on the provision and demand aspect”.
In its earlier plea, the affiliation has stated that notifying the gadgets as medicine will end in a considerable hike of their costs which might make them unaffordable for a big section of society.